BRAF and neoplasm: Some previous studies have linked BRAF mutation with poorer prognosis52,53 in pLGG, though others have found conflicting findings.48 We hypothesize that the effect of BRAF mutational status on recurrence is complex and may be dependent on the particular subtype of BRAF mutation, other tumor genomic factors, clinical factors, and radiomics.48,54